Skip to main content

Publications

Selected Recent Publications

  • Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF: Combination therapy with sirolimus and mycophenolate mofetil: Effects on the kidney and on transforming growth factor-ß. Transplantation. 77(5): 683-686, 2004
  • Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF: Sirolimus increases transforming growth factor-ß1 expression and potentiates chronic cyclosporine nephrotoxicity. Kidney Int. 65(4): 1262-1271, 2004
  • Shihab FS, Bennett WM, Yi H, Andoh TF: Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity. Transplantation. 79(4): 419-426, 2005
  • Crompton JA, Alexander D, Somerville T, Shihab FS: Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Transplant Infect Dis. 6(4): 183-187, 2004
  • McDevitt LM, Smith LD, Somerville KT, Corbett JL, Shihab FS: A retrospective assessment of pre-treatment variables on the response to darbepoetin alfa after renal transplantation. Am J Transplant. 5(8): 1948-1956, 2005
  • Shihab FS, Bennett WM, Yi H, Andoh TF: Effect of cyclosporine and sirolimus on the expression of connective tissue growth factor in rat experimental chronic nephrotoxicity. Am J Nephrol. 26(4): 400-407, 2006
  • Buchanan C, Smith L, Corbett J, Nelson E, Shihab F: A retrospective analysis of ezetemibe treatment in renal transplant recipients. Am J Transplant. 6(4): 770-774, 2006
  • Shihab FS, Waid TH, Conti DJ, Yang H, Holman MJ, Mulloy LC, Henning AK, Holman J Jr, First MR; CRAF Study Group: Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF study. Transplantation. 85(9): 1261-1269, 2008
  • Shihab FS, Bennett WM, Andoh TF: Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Transplantation. 87(3): 326-329, 2009
  • Delgado JC, Pavlov IY, Shihab FS: Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study. Transplant Immunol. 22(1-2): 1-4, 2009
  • Shihab FS, Bennett WM, Andoh TF: Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation. Am J Nephrol. 31(2): 134-140, 2010
  • Goldfarb-Rumyantzev AS, Sandhu GS, Baird B, Barenbaum A, Yoon JH, Dimitri N, Koford JK, Shihab F: Effect of education on racial disparities in access to kidney transplantation. Clin Transplant. 2010 Dec 27 PMID: 21198857
  • Goldfarb-Rumyantzev AS, Wright S, Ragasa R, Ostler D, Van Orden J, Smith L, Efimova E, Emerson L, Sandhu GS, Shihab F: Factors associated with nonadherence to medication in kidney transplant recipients. Nephron Clin Pract. 117(1): c33-c39, 2011
  • Brennan DC, Legendre C, Patel D, Mange K, Wiland A, McCague K, Shihab FS: Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: Pooled analysis of three clinical trials. Am J Transplant. 11(11): 2453-2462, 2011
  • Sikora M, Shaaban A, Beddhu S, Bourija H, Wei G, Baird B, Truax C, Shihab FS: Effect of donor kidney volume on recipient outcome: Does the “dose” matter? Transplantation. 94(11): 1124-1130, 2012
  • Sikora M, Truax C, Lee S, Kenyon N, Smith L, Corbett J, Shihab F: Low-dose fluconazole prophylaxis in kidney transplant recipients receiving tacrolimus. Clin Transplant. 26(5): E555-E560, 2012
  • Shihab FS, Lee S, Smith LD, Woodle ES, Pirsch JD, Gaber AO, Henning AK, Reisfield R, Fitzsimmons W, Holman J, First MR: Effect of corticosteroid withdrawal versus continuation on tacrolimus and mycophenolate mofetil exposure in a prospective multicenter study. Am J Transplant. 13(2): 474-484, 2013
  • Shihab FS, Cibrik D, Chan L, Kim YS, Carmellini M, Walker R, Zibari G, Pattison J, Cornu-Artis C, Wang Z, Jiang H, Tedesco-Silva Jr H: Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine. Clin Transplant. 27(2): 217-226, 2013
  • Melancon K, Mulgaonkar SP, Delcoro C, Wiland A, McCague K, Shihab FS: Outcomes in ethnic minority renal transplant recipients receiving everolimus vs. mycophenolate: comparative risk assessment results from a pooled analysis. Transplantation 96(12): 1073-1081, 2013

Note: For a more complete list of publications, please visit Dr. Shihab PubMed page.

Fuad Shihab, MD

Professor,

Nephrology & Hypertension

fuad.shihab@hsc.utah.edu

View Profile